Finance

Lists
NKTX:NASDAQ
Nkarta Inc
$2.54
+5.39%
(+0.13) 1D
$2.54
0.00% (0.00)
After hours
Closed: Aug 19, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NKTX...
Open
$2.47
High
$2.60
Low
$2.47
Mkt. cap
181.93M
Avg. vol.
658.61K
Volume
0.00
52-wk high
$3.72
52-wk low
$1.70
EPS
-$1.58
Beta
0.93
Shares outstanding
71.62M
No. of employees
106
Open
$2.47
High
$2.60
Low
$2.47
Mkt. cap
181.93M
Avg. vol.
658.61K
Volume
0.00
52-wk high
$3.72
52-wk low
$1.70
EPS
-$1.58
Beta
0.93
Shares outstanding
71.62M
No. of employees
106
News stories
From web sources and news partners
About Nkarta Inc
CEO-
Employees106
Founded2015
HeadquartersSouth San Francisco, California, United States
SectorBiotechnology
Websitenkartatx.com
Analyst ratings
Based on 5 analysts giving stock ratings to NKTX in the past 3 months
Strong buy
Buy
5
Hold
0
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for NKTX in the last 3 months.
Highest
Current $2.54
$14.00 (+451.18%)
Average
$11.75 (+362.60%)
Lowest
$10.00 (+293.70%)
Analyst
Recommendation
Action
Price target
Projected
Date
Salim Syed
Mizuho Securities
Buy
Maintained
$12.00
+372.4%
08/17/2026
Stephen Willey
Stifel Nicolaus
Buy
Maintained
$10.00
+293.7%
08/14/2026
Gil Blum
Needham
Buy
Maintained
$11.00
+333.1%
08/11/2026
Emily Bodnar
H.C. Wainwright
Buy
Reiterated
$14.00
+451.2%
08/11/2026
Phil Nadeau
TD Cowen
Buy
Maintained
-
-
08/10/2026
Jonathan Miller
Evercore ISI
Buy
Maintained
$9.00
+254.3%
05/18/2026
Yaron Werber
TD Cowen
Buy
Maintained
-
-
03/26/2026
Last report
Aug 10, 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
-$0.54 / -$0.36
-48.63%miss
Revenue / Est. (USD)
- / 0.00
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
20.20M
25.28M
24.99M
29.05M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6.30M
5.31M
5.89M
6.03M
Operating expense
26.50M
30.59M
30.88M
35.08M
Total operating expenses
26.50M
30.59M
30.88M
35.08M
Operating income
-26.50M
-30.59M
-30.88M
-35.08M
Other non operating income
1.72M
162.00K
206.00K
222.00K
EBT including unusual items
-21.72M
-27.41M
-27.83M
-40.37M
EBT excluding unusual items
-20.92M
-27.14M
-27.83M
-32.32M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-21.72M
-27.41M
-27.83M
-40.37M
Net profit margin
-
-
-
-
Earnings per share
-0.29
-0.37
-0.37
-0.54
Interest and investment income
3.85M
3.30M
2.84M
2.54M
Interest expense
-
-
-
-
Net interest expenses
3.85M
3.30M
2.84M
2.54M
Depreciation and amortization charges
-
-
-
-
EBITDA
-24.19M
-28.34M
-28.54M
-32.35M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps